Stepping into 2026, the healthcare private equity landscape is defined by both powerful momentum and meaningful constraints. Record levels of dry powder and a growing pipeline of high‑quality assets suggest increased deal activity, while stabilizing macroeconomic conditions and the potential for interest‑rate relief offer real tailwinds. Yet investors face an environment shaped by intensifying state and federal oversight, evolving reimbursement models, and disciplined pricing pressures—particularly for premium assets. At the same time, AI‑driven transformation is reshaping diligence, operations, and value creation across sectors such as infusion therapy, specialty pharmacy, behavioral health, value‑based care, and post‑acute services.
Read the full article: 2026 Healthcare Private Equity Outlook & Trends //
Source: https://insights.bassberry.com/link/759610/